Our mission is to build the first universal AI foundation model for biology to fuel breakthrough discoveries and accelerate innovations in biomedicine and beyond.
Total raised: $35M
Funding Rounds 1
Date | Series | Amount | Investors |
20.02.2024 | Seed | $35M | - |
Mentions in press and media 6
Date | Title | Description |
07.08.2024 | From labs to market: 10 promising biotech startups based in France | The biotech sector in France has always been a pivotal player in Europe’s life sciences landscape. As mentioned in our previous article focused on biotech companies in the UK, this field spans not only healthcare but also sectors such as ag... |
21.02.2024 | Bioptimus: Pioneering AI in Biology | Bioptimus, a Paris-based biotech startup, has secured a hefty $35 million in seed funding to propel its groundbreaking AI foundational model focused on biology. Led by CEO Jean-Philippe Vert, the company aims to revolutionize scientific res... |
20.02.2024 | Bioptimus raises $35 million seed round to develop AI foundational model focused on biology | There’s a new generative AI startup based in Paris. But what makes Bioptimus interesting is that it plans to apply everything we’ve collectively learned about AI models over the past few years with a narrow, exclusive focus on biology. The ... |
20.02.2024 | Google DeepMind alumni unveil Bioptimus: Aiming to build first universal biology AI model | As the French startup ecosystem continues to boom — think Mistral, Poolside, and Adaptive — today the Paris-based Bioptimus, with a mission to build the first universal AI foundation model for biology, emerged from stealth following a seed ... |
20.02.2024 | Bioptimus Raises $35M in Seed Funding | Bioptimus, a Paris, France-based biotechnology company providing an AI foundation model for the research, raised $35M in funding. The round was led by Sofinnova Partners, and Bpifrance Large Venture, with participation from Frst, Cathay Inn... |
- | Bioptimus | “Our mission is to build the first universal AI foundation model for biology to fuel breakthrough discoveries and accelerate innovations in biomedicine and beyond.” |